Pasithea Therapeutics Corp Stock Analysis

Pasithea Stock Analysis Notes

About 23.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.22. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pasithea Therapeutics recorded a loss per share of 14.79. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 2nd of January 2024. Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida. Pasithea Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. To find out more about Pasithea Therapeutics Corp contact Tiago Marques at 702 514 4174 or learn more at https://www.pasithea.com.

Pasithea Therapeutics Investment Alerts

Pasithea Therapeutics Upcoming and Recent Events

Pasithea Largest EPS Surprises

View All Earnings Estimates

Pasithea Therapeutics Environmental, Social, and Governance (ESG) Scores

Pasithea Stock Institutional Investors

Note, although Pasithea Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pasithea Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.93 M.

Pasithea Profitablity

Management Efficiency

Pasithea Therapeutics has return on total asset (ROA) of (0.379) % which means that it has lost $0.379 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6325) %, meaning that it created substantial loss on money invested by shareholders. Pasithea Therapeutics' management efficiency ratios could be used to measure how well Pasithea Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.9. In addition to that, Return On Capital Employed is expected to decline to -0.71. At present, Pasithea Therapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 62.1 M, whereas Non Current Assets Total are forecasted to decline to about 5.7 M.

Technical Drivers

As of the 25th of November, Pasithea Therapeutics holds the Variance of 85.01, coefficient of variation of (3,503), and Risk Adjusted Performance of (0.01). Pasithea Therapeutics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices.

Pasithea Therapeutics Price Movement Analysis

Pasithea Therapeutics Insider Trading Activities

Pasithea Therapeutics Outstanding Bonds

Pasithea Therapeutics Predictive Daily Indicators

Pasithea Therapeutics Corporate Filings

Pasithea Therapeutics Forecast Models

Pasithea Therapeutics' time-series forecasting models are one of many Pasithea Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pasithea Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pasithea Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pasithea shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pasithea Therapeutics. By using and applying Pasithea Stock analysis, traders can create a robust methodology for identifying Pasithea entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pasithea analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pasithea analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pasithea Therapeutics Corp stock analysis indicators help investors evaluate how Pasithea Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pasithea Therapeutics shares will generate the highest return on investment. By understating and applying Pasithea Therapeutics stock analysis, traders can identify Pasithea Therapeutics position entry and exit signals to maximize returns.

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.